Related Experiment Video
Updated: Jan 17, 2026

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers
Published on: March 3, 2023
Successful Treatment of Refractory Bilateral Leg Ulcers With an Adsorptive Blood-Purification Device
Asako Iida1, Goh Akiyama1, Kaoruko Matsunami1
1From the Department of Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School Hospital, Tokyo, Japan.
Insights
Rheocarna, a novel blood purification device, shows promise for treating chronic limb-threatening ischemia (CLTI) in patients ineligible for revascularization. This therapy improved circulation and ulcer healing, potentially preventing amputation in a challenging case.
Area of Science:
- Vascular Medicine
- Medical Devices
- Nephrology
Background:
- Chronic limb-threatening ischemia (CLTI) represents the most severe stage of lower extremity artery disease.
- Patients with CLTI often present with complex comorbidities and limited treatment options, particularly if unsuitable for revascularization.
- Existing therapies for CLTI have limitations, necessitating exploration of novel treatment modalities.
Abstract:
Chronic limb-threatening ischemia (CLTI) is the most advanced stage of lower extremity artery disease. Patients with CLTI are often unsuitable for revascularization and thus have limited treatment options. In 2020, Japan approved Rheocarna for such cases. Rheocarna is an adsorptive blood-purification device that removes low-density lipoprotein cholesterol and fibrinogen. We presented the case of a 63-year-old man with chronic kidney disease and diabetes mellitus who presented with severe and progressing refractory ulcers. Angiography revealed severe arterial calcification, indicating CLTI. No targets for standard revascularization treatment were found. Together with wound care and hyperbaric oxygen, 20 Rheocarna treatment sessions improved circulation and ulcer healing, thus avoiding amputation. Thus, Rheocarna may be a promising therapy for CLTI patients who are ineligible for revascularization. Further studies are needed to validate its efficacy.
Related Concept Videos
Peripheral Artery Disease V: Postoperative Nursing Management
Varicose Veins II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care

